Portal de Periódicos da CAPES

Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation

2019; Elsevier BV; Volume: 1861; Issue: 7 Linguagem: Inglês

10.1016/j.bbamem.2019.05.003

1879-2642

Aleyda Benitez‐Amaro, Chiara Pallara, Laura Nasarre, Andrea Rivas-Urbina, Sònia Benı́tez, Àngela Vea, Olga Bornachea, David de Gonzalo‐Calvo, Gabriel Serra-Mir, Sandra Villegas, Roger Prades, Jose Luís Sánchez‐Quesada, Cristina Chiva, Eduard Sabidó, Teresa Tarragó, Vicenta Llorente‐Cortés,

Proteins in Food Systems

Aggregated LDL is the first ligand reported to interact with the cluster II CR9 domain of low-density lipoprotein receptor-related protein 1 (LRP1).In particular, the C-terminal half of domain CR9, comprising the region Gly1127-Cys1140 exclusively recognizes aggregated LDL and it is crucial for aggregated LDL binding.Our aim was to study the effect of the sequence Gly1127-Cys1140 (named peptide LP3 and its retro-enantio version, named peptide DP3) on the structural characteristics of sphingomyelinase-(SMase) and phospholipase 2 (PLA2)modified LDL particles.Turbidimetry, gel filtration chromatography (GFC) and tomography electronic microscopy (TEM) analysis showed that LP3 and DP3 peptides strongly inhibited SMase-and PLA2-induced LDL aggregation.Nondenaturing polyacrylamide gradient gel electrophoresis (GGE), agarose gel electrophoresis and high-performance thin-layer chromatography (HPTLC) indicated that LP3 and DP3 prevented SMase-induced alterations in LDL particle size, electric charge and phospholipid content, respectively, but not those induced by PLA2.Western blot analysis showed that LP3 and DP3 counteracted changes in ApoB-100 conformation induced by the two enzymes.LDL proteomics (LDL trypsin digestion followed by mass spectroscopy) and computational modeling methods evidenced that peptides protect ApoB-100 conformation due to their electrostatic interactions with a basic region of ApoB-100.These results demonstrate that LRP1derived peptides are protective against LDL aggregation, even in conditions of extreme lipolysis, through their capacity to bind to ApoB-100 regions critical to preserve ApoB-100 conformation.These results suggests that these LRP1(CR9) derived peptides could be promising tools to prevent LDL aggregation induced by the main proteolytic enzymes acting in the arterial intima.